DEUTSCHE BANK AG\ - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 44 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$26,000
-64.9%
11,343
-10.6%
0.00%
Q4 2021$74,000
-41.3%
12,683
+5.5%
0.00%
Q3 2021$126,000
+180.0%
12,021
+158.3%
0.00%
Q2 2021$45,000
-82.3%
4,653
-73.3%
0.00%
Q1 2021$254,00017,4320.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$580,0000.02%
Virtu Financial LLC 15,980$93,0000.01%
Jump Financial, LLC 11,800$68,0000.00%
Investment Research & Advisory Group, Inc. 1,400$4,0000.00%
Cubist Systematic Strategies, LLC 12,804$74,0000.00%
UBS Group AG 22,402$130,0000.00%
RHUMBLINE ADVISERS 18,894$110,0000.00%
Ellevest, Inc. 18$00.00%
TWO SIGMA INVESTMENTS, LP 28,771$167,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,105$64,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders